Novanta (NOVT)BAMCO Inc reduced its stake -65K shares

850K

Shares reported · -65K vs prior quarter

0.21%

Disclosed portfolio weight

$138M

Reported value

Holdings as of

Jun 30, 2026

Filed

Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 22, 2026Company filing · Form 8-K · Acquisition or sale, New debtCompleted buying or selling a business or assets, and took on new debt or obligations (and 1 more item)“As previously disclosed in the Current Report on Form 8-K filed on June 8, 2026 (the “ Previous Form 8-K ”), by Novanta Inc., a Canadian corporation (the “ Company ”) with the Securities and Exchange Commission, on June 8, 2026, the Company, Novanta Medical Technologies Corp., a Delaware corporation and an indirect subsidiary of the Company (“ Buyer ”), Novanta Corporation, a Michigan corporation (“ Intermediate…”
2. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Novanta

For Novanta, OQRO holds 9 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NOVT page.

How this filing works

• SEC Form 13F

Other disclosures at Novanta

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 12, 2026

Everything OQRO holds on this company is on its NOVT page.